Author

V. Clemente

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2 Cell Biology· 1 Pathology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Organism:human· 3 Assay:bulk RNA-seq· 2 Research Focus:cancer & tumor microenvironment· 2 Assay:clinical cohort / trial· 1 Research Focus:differential expression· 1 Research Focus:gene regulatory network inference· 1 Approach:statistical model· 1

Frequent Co-Authors

M. Bazzaro· 4 shared M. Shetty· 3 shared A. Hoshino· 2 shared E. Lou· 2 shared A. C. Nelson· 1 shared A. Nelson· 1 shared A. Staebler· 1 shared A. Svedbom· 1 shared

Activity by Year

2021-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 27 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

4 shared papersCancer Biology

M. Bazzaro

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

The Microtubule Severing Protein UNC-45A Counteracts the Microtubule Straightening Effects of Taxol

A. Hoshino, V. Clemente, M. Shetty, B. Castle, D. Odde, M. Bazzaro

This paper shows UNC-45A increases microtubule curvature and counteracts Taxol's straightening effects, suggesting a role in drug resistance.

bioRxiv · Sep 12, 2023 · PreprintCell Biology

Clinical Significance of the Stromatic Component in Ovarian Cancer: Quantity Over Quality in Outcome Prediction

E. Lou, V. Clemente, M. Grube, A. Svedbom, A. C. Nelson, F. Blome, A. Staebler, S. Kommoss, M. Bazzaro

This study shows that higher tumor-stroma proportion (TSP) in ovarian cancer is linked to worse patient outcomes, including shorter progression-free and overall survival, and increased chemoresistance.

bioRxiv · Jun 27, 2023 · PreprintPathology

GLS1 is a Protective Factor Rather than a Molecular Target in ARID1A-Mutated Ovarian Clear Cell Carcinoma

V. Clemente, A. Nelson, B. Erickson, R. Baker, N. Rubin, M. Khalifa, A. Hoshino, M. Shetty, E. Lou, M. Bazzaro

The paper investigates GLS1 expression in ARID1A-mutated ovarian clear cell carcinoma and finds it is not correlated with ARID1A loss and is associated with better clinical outcomes.

bioRxiv · Sep 3, 2021 · PreprintCancer Biology

Targeting Mitochondrial Metabolism in Clear Cell Carcinoma of the Ovaries

M. Bazzaro, S. Linder, M. Shetty, X. Zhang, V. Clemente

This study shows that loss of ARID1A increases mitochondrial metabolism in OCCC and that inhibiting mitochondrial complex I improves survival in preclinical models.

bioRxiv · Feb 17, 2021Cancer Biology